Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech ...

Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?

We often focus on covering the innovation side of the biotech industry – we describe how promising investigational drugs work, what trends shape the biotech industry, and the companies within it. But ...

Bugworks, which is headquartered in the U.S. with subsidiaries in India and Australia, specializes in the development of antibiotics that could address the growing crisis of antimicrobial resistance.

Idiopathic pulmonary fibrosis (IPF) is a rare condition where the lungs become scarred, making it hard to breathe. The cause of the disease is unknown, which is why it is called ‘idiopathic.’ So far, ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

As touched upon, a few decades ago, Japan was a global powerhouse when it came to biopharma innovation, as companies in the country invested heavily in research and development (R&D), aided at the ...

The biggest private biotech funding round of November 2024 went to Metsera, which raised $215 million in series B funding. The company is focused on advancing the next generation of therapies for ...